Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store? [Yahoo! Finance]
Puma Biotechnology Inc (PBYI)
Last puma biotechnology inc earnings: 2/20 04:07 pm
Check Earnings Report
US:NYSE Investor Relations:
pumabiotechnology.com/ir.html
Company Research
Source: Yahoo! Finance
candidate, alisertib, when it reports fourth-quarter and full-year 2023 results on Feb 29 after market close. Let's see how things have shaped up for the quarter to be reported. Factors at Play Puma Biotechnology's top line comprises sales of Nerlynx in the United States and license fees from its sub-licensees and royalty revenues. Nerlynx is indicated for treating early-stage HER2-positive breast cancer. Total revenues are likely to have witnessed a decline in the to-be-reported quarter owing to lower Nerlynx sales. In the last reported quarter, product revenues from Nerlynx were hurt by inventory drawdown at specialty pharmacies and specialty distributors. It remains to be seen whether the same trend continued or reversed in the to-be-reported quarter. Shares of PBYI have rallied 64.9% in the past year against the industry's decline of 7.3%. Image Source: Zacks Investment Research Also, in the last reported quarter, royalty revenues increased year over year due to th
Show less
Read more
Impact Snapshot
Event Time:
PBYI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PBYI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PBYI alerts
High impacting Puma Biotechnology Inc news events
Weekly update
A roundup of the hottest topics
PBYI
News
- Puma Biotechnology, Inc. (NASDAQ: PBYI) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results [Yahoo! Finance]Yahoo! Finance
- Puma Biotechnology: A Story In Flux Heading Into Mid-2024 [Seeking Alpha]Seeking Alpha
- Puma Biotechnology, Inc. (NASDAQ: PBYI) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Puma Biotechnology, Inc. (NASDAQ: PBYI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.MarketBeat
PBYI
Earnings
- 5/2/24 - Beat
PBYI
Analyst Actions
- 5/3/24 - HC Wainwright
PBYI
Sec Filings
- 5/2/24 - Form 10-Q
- 5/2/24 - Form 8-K
- 4/26/24 - Form DEFA14A
- PBYI's page on the SEC website